Single Photon Emission Tomography Approach for Online Patient Dose Assessment in Boron Neutron Capture Therapy

Similar documents
Epithermal neutron beams from the 7 Li(p,n) reaction near the threshold for neutron capture therapy

Boron Neutron Capture Therapy (BNCT) - Low-Energy Neutron Spectrometer for Neutron Field Characterization - )

Radiation Protection in BNCT Patients

Progress in Reactor and Accelerator Based BNCT at Kyoto University Research Reactor Institute

Study of neutron-dna interaction at the IPEN BNCT Research facility ABSTRACT

V. 4. Design and Benchmark Experiment for Cyclotron-based Neutron Source for BNCT

Optimization of an accelerator-based epithermal neutron source for neutron capture therapy

Neutrons. ρ σ. where. Neutrons act like photons in the sense that they are attenuated as. Unlike photons, neutrons interact via the strong interaction

THERMOLUMINESCENT (TL) DOSIMETRY OF SLOW-NEUTRON FIELDS AT RADIOTHERAPY DOSE LEVEL

Neutron - a tool in the cancer treatment - C. Paunoiu

COMPARING THE RESPONSES OF TLD 100, TLD 600, TLD 700 AND TLD 400 IN MIXED NEUTRON-GAMMA FIELDS

Radiation Dosimetry at the BNL High Flux Beam Reactor and Medical Research Reactor

Thin Beryllium target for 9 Be(d,n)- driven BNCT

Preliminary study of MAGAT polymer gel dosimetry for boron-neutron capture therapy

Radiation Detection and Measurement

Comparison between proton boron fusion therapy (PBFT) and boron neutron capture therapy (BNCT): a Monte Carlo study

Investigating a cyclotron HM-30 based neutron source for BNCT of deep-seated tumors by using shifting method

Title. Author(s)Ishikawa, Masayori; Tanaka, Kenichi; Endo, Satrou; H. CitationJournal of Radiation Research, 56(2): Issue Date

AUTHOR QUERIES - TO BE ANSWERED BY THE CORRESPONDING AUTHOR

Calculation methods in Hermes Medical Solutions dosimetry software

IPPE Iron shell transmission experiment with 14 MeV neutron source and its analysis by the Monte-Carlo method

A Feasibility Study of the SLOWPOKE-2 Reactor as a Neutron Source for Boron Neutron Cancer Treatment

Neutron Interactions Part 2. Neutron shielding. Neutron shielding. George Starkschall, Ph.D. Department of Radiation Physics

GDR in Radiotherapy Treatment Fields with 18 MV Accelerators

Plastic scintillation detectors for dose monitoring in digital breast tomosynthesis

THE HIGH-CURRENT DEUTERON ACCELERATOR FOR THE NEUTRON THERAPY. S.V. Akulinichev, A. V. Andreev, V.M. Skorkin

Design and Performance Of A Thermal Neutron Beam for Boron Neutron Capture Therapy At The University Of Missouri Research Reactor

Chapter Introduction

Djoko S. Pudjorahardjo, Widarto, Isman Mulyadi T

Neutron Induced Radiation Damage in BaF 2, LYSO and PWO Scintillation Crystals

On the optimal energy of epithermal neutron beams for BNCT

PHYSICS 2: HSC COURSE 2 nd edition (Andriessen et al) CHAPTER 20 Radioactivity as a diagnostic tool (pages 394-5)

Neutron sources from Nuclear Reactors

Numerical optimisation of the fission-converter and the filter/moderator arrangement for the Boron Neutron Capture Therapy (BNCT)

Today, I will present the second of the two lectures on neutron interactions.

LA-UR- Title: Author(s): Submitted to: Approved for public release; distribution is unlimited.

MODELLING A GAMMA IRRADIATION PROCESS USING THE MONTE CARLO METHOD

Simulation of the BNCT of Brain Tumors Using MCNP Code: Beam Designing and Dose Evaluation

Real Time Spectrometer for thermal neutrons from Radiotherapic Accelerators

Design of Moderator Neutron for Boron Neutron Capture Therapy in Kartini Nuclear Reactor Using Monte Carlo N Particle 5 Simulation

PhD értekezés tézisei PHASE I CLINICAL STUDY ON BORON NEUTRON CAPTURE THERAPY. Dr Katalin Hideghéty. A Doktori Iskola vezetıje Prof. Dr.

A D-D/D-T Fusion Reaction Based Neutron Generator System for Liver Tumor BNCT

The physics of boron neutron capture therapy: an emerging and innovative treatment for glioblastoma and melanoma

Application of MCNP4C Monte Carlo code in radiation dosimetry in heterogeneous phantom

Radiotherapy. Marta Anguiano Millán. Departamento de Física Atómica, Molecular y Nuclear Facultad de Ciencias. Universidad de Granada

University of Wollongong. Research Online

I. Cancer staging problem

Distribution of Water Phantom BNCT Kartini Research Reactor Based Using PHITS

Development of a portable gamma imaging system for absorbed radia4on dose control in targeted radionuclide therapy

EUROPEAN ORGANIZATION FOR NUCLEAR RESEARCH. Proposal to the ISOLDE and Neutron Time-of-Flight Committee

RPI DOSIMETRY. Therefore the description of the work is grouped in two main areas:

A Snapshot on Nuclear Cardiac Imaging

EPITHERMAL NEUTRON BEAM GENERATOR DESIGN FOR BNCT

CALIBRATION OF A TLD ALBEDO INDIVIDUAL NEUTRON MONITOR

Medical- and Radiation Physics Research at Surrey

Dosimetric characterization with 62 MeV protons of a silicon segmented detector for 2D dose verifications in radiotherapy

Design of a BSA for Producing Epithermal Neutron for BNCT

Comparison of dosimetry parameters of two commercially available Iodine brachytherapy seeds using Monte Carlo calculations

The title of the presentation is: Neutron production with clinical LINACs for BNCT studies in physical, medical and biological fields.

Option D: Medicinal Chemistry

JRPR. Quenching Effect in an Optical Fiber Type Small Size Dosimeter Irradiated with 290 MeV u -1 Carbon Ions. Original Research.

Production and dosimetry of simultaneous therapeutic photons and electrons beam by linear accelerator: a monte carlo study

Radiation physics and radiation protection. University of Szeged Department of Nuclear Medicine

Physical Bases : Which Isotopes?

45 Hr PET Registry Review Course

Development of LINAC-Based Neutron Source for Boron Neutron Capture Therapy in University of Tsukuba )

Dosimetry Optimization System and Integrated Software (DOSIS): a comparison against Fluka code results over a standard phantom

Venue: IEEE NSS/MIC/RTSD Conference, Seoul, South Korea, 27 th October 2013 Workshop: NWK3/RD1 Radiation Protection and Dosimetry

Feasibility of BNCT and Neutron Imaging with 1Hz, 5kJ Plasma Focus Neutron Source at the ICTP-MLAB Laboratory

Dosimetric characterization with 62 MeV protons of a silicon segmented detector for 2D dose verifications in radiotherapy

[Setawati et. al., Vol.4 (Iss10): October, 2017] ISSN: DOI: /zenodo

Dosimetric characteristics of 137 Cs sources used in after loading Selectron system by Monte Carlo method

Development and characteristics of the HANARO ex-core neutron irradiation facility for applications in the boron neutron capture therapy field

Determination of Iodine in Biological Materials using Instrumental Neutron Activation and Anti-coincidence Gamma-ray Spectrometry

Medical Use of Radioisotopes

Monte Carlo simulation of 192 Ir radioactive source in a phantom designed for brachytherapy dosimetry and source position evaluation.

Biases affecting tumor uptake measurements in FDG-PET

PHYS 383: Applications of physics in medicine (offered at the University of Waterloo from Jan 2015)

Correction of Prompt Gamma Distribution for Improving Accuracy of Beam Range Determination in Inhomogeneous Phantom

FINAL TECHNICAL REPORT MICRODOSIMETRY FOR BORON NEUTRON CAPTURE THERAPY DE - FG02-96ER62217

Theragnostics for bone metastases. Glenn Flux Royal Marsden Hospital & Institute of Cancer Research Sutton UK

Reproducibility of Uptake Estimates in FDG PET: a Monte Carlo study

Introduction. Measurement of Secondary Radiation for Electron and Proton Accelerators. Introduction - Photons. Introduction - Neutrons.

Calculation of Dose Distribution Around a Clinical 252. Cf Source for Neutron Therapy Based on AAPM, TG-43 Protocol

III. Proton-therapytherapy. Rome SB - 5/5 1

Topics covered 7/21/2014. Radiation Dosimetry for Proton Therapy

Application of the Multi-Model Monte-Carlo Treatment Planning System Combined with PHITS to Proton Radiotherapy

Dose distribution and dosimetry parameters calculation of MED3633 palladium-103 source in water phantom using MCNP

CALCULATION OF BACKSCATTER FACTORS FOR LOW ENERGY X-RAYS USING THE TOPAS MONTE CARLO CODE

Imaging of Radiation Dose Using Cherenkov Light

Characterization and implementation of Pencil Beam Scanning proton therapy techniques: from spot scanning to continuous scanning

SOME RECENT DEVELOPMENTS IN TREATMENTPLANNING SOFTWARE A N D METHODOLOGY FOR BNCT

Toshiba Aquillion 64 CT Scanner. Phantom Center Periphery Center Periphery Center Periphery

Radioactivity. Alpha particles (α) :

Monte Carlo Modelling: a reliable and efficient tool in radiation dosimetry

Treatment planning system and patient positioning for boron neutron capture therapy

Dollars and Sense: Are We Overshielding Imaging Facilities? Part 2

SIMULATION RESPONSE OF RESISTIVE PLATE CHAMBER FOR FAST NEUTRONS USING GEANT4 MC CODE

Neutron dose evaluation in radiotherapy

Application of Neutron Capture Therapy to Widespread Tumours

Transcription:

Single Photon Emission Tomography Approach for Online Patient Dose Assessment in Boron Neutron Capture Therapy Daniel M Minsky a,b,c*, Alejandro Valda a,b, Andrés J Kreiner a,b,c and Alejandro A Burlon a,b a Comisión Nacional de Energía Atómica, Departamento de Física, Av. Gral. Paz 1499, 1650, San Martín, Argentina b Universidad Nacional de San Martín, Escuela de Ciencia y Tecnología, M. de Irigoyen 3100, 1650, San Martín, Argentina c CONICET, Av. Rivadavia 1917, 1033, Buenos Aires, Argentina Abstract. A tomographic imaging system for the measurement of the spatial distribution of the absorbed dose during a Boron Neutron Capture Therapy (BNCT) session is presented. The 10 B(n,α) 7 Li boron neutron capture reaction produces a 478 kev gamma ray in 94% of the cases. Therefore its detection can serve as a basis for a non-invasive online absorbed dose determination since the dose absorbed by the tumor and healthy tissue strongly depends on the boron uptake and the neutron flux. For this purpose, a dedicated tomographic imaging system based on Single Photon Emission Computed Tomography is proposed. Monte Carlo numerical simulations are used for the system design aimed to have a spatial resolution of 1 cm. Prototypes based on CdZnTe semiconductor detectors and LaBr 3 (Ce) scintillators with optimized shielding were designed with Monte Carlo simulations. They were built and tested in reactor and accelerator based BNCT facilities. A projection of a phantom with two tumors with 400 ppm of 10 B was successfully measured at the accelerator facility of the University of Birmingham. KEYWORDS: BNCT; SPECT; dosimetry; prompt-gamma detection. 1. Introduction Boron neutron capture therapy (BNCT) [1] is a radiation therapy modality under development for the treatment of some types of cancers like melanoma and glioblastoma multiforme. It is performed in two steps: first, a stable isotope of boron ( 10 B) is administered to the patient via a carrier drug and then the patient is irradiated with an epithermal neutron beam. The neutrons are moderated as they penetrate into the patient s tissue and reach the tumor with thermal energy. 10 B has a high thermal neutron capture cross section (3840 b) leading to the 10 B(n,α) 7 Li reaction. The emitted charged particles have a high linear energy transfer (LET) and they deliver all their energy (1.47 MeV for the α particle and 0.84 MeV for the 7 Li) in a short range (9 µm for the α particle and 5 µm for the 7 Li). Hence only the cells in close proximity to the reaction point may suffer a lethal effect. In BNCT the dose delivered to a patient depends both on the neutron beam quality and on the selectivity and concentration of the drug used as the boron vector. As a consequence of the several neutron interactions with the different nuclei present in tissue, the dose delivered has several components with high and low LET. However in tumors having a typical boron concentration of 40 ppm, the neutron capture reactions in boron contribute to about 80 % of the total dose. The boron concentrations in tumour and in healthy tissue needed for the dose assessment are currently inferred from (a) the pharmacokinetics of the boron compound obtained from biodistribution studies not necessarily performed on the specific patient to be treated and (b) the measurement of 10 B concentration in patient s blood samples before and after irradiation. This method has large uncertainties due to patient-to-patient variability and provides only global concentration values in tumour and in healthy tissue. Finally the patient dose is evaluated from these 10 B concentrations together with a simulated neutron flux. * Presenting author, E-mail: minsky@tandar.cnea.gov.ar 1

A better technique is hence necessary to improve the dosimetry in BNCT. In this regard it is important to point out that in 94 % of the neutron captures in 10 B, the 7 Li ion is emitted in an excited state which promptly decays through a characteristic 478 kev gamma-ray. As the linear attenuation coefficient in tissue at this energy is about 0.1 cm -1, the gamma-rays escape out of the patient s body to a large extent. Therefore the extracorporeal measurement of the 478 kev prompt-gamma radiation can be performed and directly related to the boron dose component. Moreover, the use of a radiation detection system with imaging (in particular, tomographic) capabilities could provide a non-invasive way to determine the boron dose distribution (dose mapping) delivered to the patient as well as an online dose monitoring. Several groups have studied different approaches for this online dosimetry [2, 6]. In this work we present the design of a SPECT (Single-Photon Emission Computed Tomography) imaging system especially dedicated to operate under the particular conditions (gamma-ray and neutron radiation background) present in a BNCT treatment room. The system is designed in order to provide the boron dose distribution with a spatial resolution of about 1 cm. Results of Monte Carlo numerical simulations for the final system are presented as well as numerical and experimental results obtained with a prototype systems using CdZnTe semiconductor detectors and LaBr 3 (Ce) scintillation detectors. 2. Design considerations for a complete system The system was designed for imaging the boron captures in a patient head. In a complete BNCT treatment there are about 2 10 9 emissions of 478 kev photons per cubic centimeter in tumor. This emission number is determined by the dose needed to obtain a significant tumor control without exceeding the maximum healthy tissue dose. Considering an intrinsic detector efficiency of the order of 10 % and a collimator geometrical efficiency of the order of 10 3 %, there is a small number of events expected to be detected during the treatment that finally will limit the image quality. As a compromise between detector efficiency and spatial resolution we designed our collimators to obtain 1 cm resolution at a distance of 20 cm with a geometrical efficiency 3.4 10 3 %. In order to largely cover a transaxial field of view of 20 cm, a collimator of 23.7 cm in lateral length was chosen; having 37 parallel holes with 4.4 mm in diameter. This collimator configuration can house an array of 37 independent detectors [6]. For the tomographic acquisition a total of 20 angular positions (evenly spaced at 9 degrees, from 0 to 171 degrees) are considered giving a total of 740 projection data. The image consists of 21 21 pixels of 1 cm 1 cm size each. The algorithm chosen for the tomographic reconstruction was Expectation Maximization - Maximum Likelihood (EM-ML) [7]. The system matrix A needed for the reconstruction was calculated by Monte Carlo numerical simulations using the MCNP v5.140 code [8]; attenuation, scatter in collimator and photoelectric absorption in the scintillator were considered. Figure 1: (a) Phantom used in the numerical simulations. (b) Reconstructed image with acquired Poisson statistical noise negligible. (c) Reconstructed image having a 10 % signal to noise ratio in the most significant projection. 2

The MCNP code was also used for simulating the acquisition of the phantom shown in Fig. 1. This phantom consists of a water-filled cylinder of 8 cm radius containing four cylindrical tumors of different radii: 0.25, 0.5, 0.75 and 1 cm. The activity concentration was 4 (arbitrary units) for tumors and 1 for the rest of the phantom in agreement with the concentration ratio between tumor and healthy tissue found for p-boronphenylalanine (BPA), the usual boron carrier drug in BNCT [1]. The energy of the simulated gamma emission was 478 kev. The simulations take into account the attenuation and scattering processes in the phantom and the collimator but no other sources of background such as gamma rays produced by neutron capture in hydrogen. Fig. 1 also shows the reconstructed images for two cases: where the statistical fluctuations (Poisson noise) in the acquired projections are negligible and where the signal to statistical fluctuation ratio in the projections is 10 %. 3. Prototype design 3.1 Collimator and detectors The collimator was designed in order to maximize the detection efficiency with a spatial resolution of 1 cm at the center of the field of view (FOV). The detector to FOV center was chosen to be 60 cm due to practical considerations. Therefore the other dimensions resulted in 0.5cm for the hole diameter and 30 cm for the collimator length with a geometric efficiency of 4.34 10-6. Two kind of detectors were tested in the prototype: CdZnTe room-temperature semiconductors and LaBr 3 (Ce) scintillation detectors. The CdZnTe have a size of 5 5 5 mm 3 and LaBr 3 (Ce) are 2.54 cm 2.54 cm (diameter height) cylindrical scintillators. The CdZnTe prototype was tested in the BNCT facility located in the RA6 reactor of the Centro Atómico Bariloche (Argentina) and the scintillatorbased prototype in the accelerator based BNCT facility (AB-BNCT) of the University of Birmingham (United Kingdom). 3.2 Shielding The shielding was designed for blocking not only gammas but also neutrons, since they can generate gamma contamination inside the detectors. The proposed shielding, in the case of the prototype for the AB-BNCT facility, consists of several layers as shown in Fig. 2: an external layer of a moderator material with high concentration of hydrogen (paraffin) mixed with lithium (14% in mass of Nat Li 2 CO 3 ) to thermalize and capture neutrons, a second layer of lead to shield from gammas and a layer of 95% 6 Li enriched lithium carbonate to capture residual thermal neutrons before reaching the detector. Figure 2: Detector shielding. A material with high hydrogen content thermalizes the neutrons, a lead layer blocks gammas and a 6 Li layer captures thermal neutrons before reaching the detectors. Collimator Paraffin with Nat Li 2CO 3 Pb 6 Li 2CO 3 Detector The proposed shielding has been simulated with MCNP 5 for different paraffin and lead thicknesses in order to estimate the expected background under the 478keV peak. Two different contributions to the background have been taken into account: the gamma background coming from outside the detectors and the gamma background generated inside them by neutron captures. The background decreases 3

with the lead thickness due to attenuation of the external gamma rays, and it also reduces with the moderator thickness since it prevents captures in the crystal and the subsequent gamma production. Due to weight and space limitations, the shielding lead and paraffin layers have been chosen to be 10 cm thick each. Under this condition the expected background count rate is 120 cps for the measurements at the AB-BNCT facility. 4. Experimental results Fig. 3 shows the built scintillator-based prototype placed in the BNCT accelerator facility of the University of Birmingham. Figure 3: Experimental setup with the shielding partially removed. Beam shapping assembly Beam Port SPECT prototype The collimator resolution has been tested with the CdZnTe detectors; Fig. 4 shows the measured and simulated responses. A simple phantom containing a 241 Am point source has been used to test the reconstruction algorithm. The source was placed in a 9.22 cm radius cylindrical phantom at 4 cm from its axis. The acquisition and reconstruction scheme was as in the designed final setup: 20 projections of 41 bins each reconstructed on a 21 21 image matrix using the EM-ML algorithm. The reconstructed image is shown in Fig. 4. Figure 4: Comparison of experimental spatial resolution of the collimators with simulations. Figure 5: Reconstructed image of a phantom with a point 241Am source. 1.2 1.0 Experimental Simulation Reconstructed Intensity [Bq] 25000 Normalized intensity 0.8 0.6 0.4 0.2 R=0.97cm 20000 15000 10000 0.0-1.0-0.5 0.0 0.5 1.0 Off-axis position [cm] 5000-10 -8-6 -4-2 0 X [cm] 2 4 6-2 0 2 4 6 810 8-8 -6-4 10-10 Y [cm] 4

A cylindrical water-filled phantom (radius 9.22 cm) containing a cylindrical tumor model (radius 3 cm) having 1000 ppm in 10 B concentration was used to perform measurements with the CdZnTe prototype in the RA6 reactor BNCT facility. Fig. 6 shows a detailed view, around the 478 kev region, of spectra obtained when the tumor is placed respectively inside and outside the detector FOV. In both of them appears the 511 kev annihilation peak. The boron capture peak is visible when the tumor is in front of the detector although it is difficult to quantify due to the low statistics caused by the low detector efficiency. Figure 6: Measured spectra (detailed view) obtained with the CdZnTe system when the tumor is (is not) in the detector FOV. 0.25 Counting Rate [s -1 ] 0.20 0.15 Tumor zone Blank zone 0.10 350 400 450 500 550 600 650 Energy [kev] The γ background was measured with the LaBr 3 (Ce) system mounted at the BNCT accelerator facility of the Birmingham University and a spurious 478 kev peak was found. Those photons came from captures in the photomultiplier tube which is made of borosilicate. A 2 mm Cd layer between the paraffin and the lead reduced this unwanted peak and also the background (Fig. 7). Figure 7: A Cd layer between paraffin and lead reduced the spurious signal coming from neutron captures in the photomultiplier tube. A projection of the water-filled phantom with two tumors (400ppm 10 B and 3cm in diameter each) has been measured (Fig. 8). Fig. 9 shows the difference between the tumor and a pure water region. The small 478 kev peak in the water measurement is due to the remaining captures in the photomultiplier tubes. The projection spectra were adjusted with a simple model: an exponential background, a Gaussian 478 kev peak and a Gaussian 511 kev annihilation peak. After correction for remnant 478 kev, the measured profile across the phantom and tumors is shown in Fig. 10. Comparison with MCNP simulations shows a very good agreement. 5

Figure 8: Cross section of the water-filled cylindrical phantom with 2 tumors with 400ppm of 10B used in the experiments. Figure 9: Spectra measured at Birmingham s BNCT facility from a tumor and at a water region. Figure 10: Measured and simulated profiles of a phantom with two tumors. The shaded areas indicate tumor positions. 4. Conclusions A tomographic device for online dosimetry in BNCT has been proposed. Monte Carlo numerical simulations were used to evaluate its imaging performance. First results indicate that it would be possible to recover boron concentrations with an uncertainty of 10 % in tumors with 2 cm in diameter. Prototypes have been designed, built and tested in a reactor-based BNCT facility and in an accelerator- 6

based one. The LaBr 3 (Ce) system performed better than CdZnTe system mainly for its better detection efficiency. A profile of a phantom has been measured showing very good agreement with the simulations. Although the background must be further reduced, this work shows the feasibility of such a system. Acknowledgements The authors wish to thank Drs. S. Green, C. Wojnecki and. Z. Ghani for their help in performing the experiments in the BNCT accelerator facility of the University of Birmingham and Drs. O. Calzetta, H.R. Blaumann and J. Longhino for their help in performing the experiments in the RA6 reactor BNCT facility at the Centro Atómico Bariloche. The authors also acknowledge the financial support provided by ANPCyT, CNEA, CONICET and UNSAM. REFERENCES [1] JA Coderre and GM Morris, The radiation biology of boron neutron capture therapy, Radiation Research, 151, 1 (1999) and references therein. [2] WFAR Verbakel and F Stecher-Rasmussen, Gamma-ray telescope for on-line measurements of low boron concentrations in a head phantom for BNCT, Nucl. Instrum. Methods A 394(1-2), 163 (1997) [3] WFAR Verbakel et al., Boron concentrations in brain during boron neutron capture therapy: in vivo measurements from the phase I trial EORTC 11961 using a gamma-ray telescope, Int. J. Radiation Oncology Biol. Phys., 55(3), 743 (2003) [4] T Kobayashi, T., Y Sakurai, M Ishikawa, A noninvasive dose estimation system for clinical BNCT based on PG-SPECT - Conceptual study and fundamental experiments using HPGe and CdTe semiconductor detectors, Med. Phys. 27(9), 2124 (2000) [5] P Munck af Rosenschöld, et al., Prompt gamma tomography during BNCT - A feasibility study, Journal of Instrumentation 1, P05003 (2006) [6] A Valda, DM Minsky, AJ Kreiner, AA Burlon and H Somacal, Development of a Tomographic System for Online Dose Measurements in BNCT (Boron Neutron Capture Therapy), Br. Jour. Phys. 35(3B), 785 (2005) [7] LA. Shepp and Y Vardi, Maximum likelihood reconstruction for emission tomography, IEEE Trans. Med. Imaging MI-1(2), 113 (1982) [8] FB Brown, RF Barrett et al., MCNP VERSION 5, Technical report LA-UR-02-3935, Los Alamos National Laboratory, 2002 7